Can a website replace your doctor for Alzheimer's risk news?
NCT ID NCT06459583
First seen Jan 14, 2026 · Last updated May 16, 2026 · Updated 20 times
Summary
This study tested whether an online platform could effectively share Alzheimer's genetic and biomarker risk results with 681 participants, compared to a video call with a healthcare provider. Researchers measured anxiety, distress, and understanding to see if the self-guided method was as good as talking to a professional. The goal was to find scalable ways to deliver sensitive health information without causing harm.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Accellacare Clinical Research Site 01
Bristol, Tennessee, 37620, United States
-
Accellacare Clinical Research Site 02
Mt. Pleasant, South Carolina, 29464, United States
Conditions
Explore the condition pages connected to this study.